Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
ABO-2015 by Suzhou Abogen Biosciences for Hematological Tumor: Likelihood of Approval
ABO-2015 is under clinical development by Suzhou Abogen Biosciences and currently in Phase I for Hematological Tumor. According to GlobalData,...